COVID prevention drug trial for seniors halted before it began
NCT ID NCT04397328
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 35 times
Summary
This study aimed to see if hydroxychloroquine could safely prevent COVID-19 in older adults living in long-term care homes. It planned to give the drug to people who were at high risk due to age and health conditions. However, the trial was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.